| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.269 | 52.814 | 58.387 | 96.387 | 104.968 | 109.389 | 111.448 | 117.151 | 137.139 | 152.306 |
| Total Income - EUR | 44.269 | 52.814 | 58.387 | 96.387 | 104.968 | 111.533 | 111.468 | 117.151 | 137.139 | 152.306 |
| Total Expenses - EUR | 35.129 | 49.388 | 55.706 | 66.579 | 82.274 | 93.403 | 104.407 | 106.224 | 129.432 | 140.805 |
| Gross Profit/Loss - EUR | 9.139 | 3.426 | 2.680 | 29.809 | 22.693 | 18.130 | 7.060 | 10.927 | 7.707 | 11.502 |
| Net Profit/Loss - EUR | 7.811 | 2.897 | 889 | 28.845 | 21.643 | 17.015 | 5.946 | 9.756 | 6.335 | 8.377 |
| Employees | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Dr. Ghizăl Gabriela Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 87 | 579 | 13.104 | 16.462 | 45.828 | 68.861 | 119.939 | 105.763 | 91.690 | 78.641 |
| Current Assets | 7.172 | 9.612 | 9.583 | 18.209 | 15.627 | 12.956 | 12.452 | 11.758 | 24.847 | 14.600 |
| Inventories | 1.347 | 1.369 | 3.466 | 952 | 2.264 | 1.120 | 183 | 1.008 | 834 | 1.242 |
| Receivables | 2.979 | 3.672 | 3.684 | 6.344 | 5.909 | 6.198 | 8.578 | 8.126 | 22.250 | 51 |
| Cash | 2.846 | 4.572 | 2.433 | 10.913 | 7.453 | 5.638 | 3.691 | 2.624 | 1.763 | 13.307 |
| Shareholders Funds | 5.283 | 2.951 | 3.790 | 32.565 | 48.520 | 64.615 | 69.128 | 79.098 | 85.194 | 84.652 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.976 | 7.240 | 18.896 | 2.106 | 12.934 | 17.202 | 63.263 | 38.422 | 31.343 | 8.589 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Ghizăl Gabriela Srl